LARYNX
Clinical trials for LARYNX explained in plain language.
Never miss a new study
Get alerted when new LARYNX trials appear
Sign up with your email to follow new studies for LARYNX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an immunotherapy combo replace harsh chemo for head and neck cancer?
Disease control OngoingThis phase II trial tests whether combining the immunotherapy drug durvalumab (Imfinzi) with radiation therapy can effectively treat intermediate-risk head and neck cancer after surgery, while causing fewer serious side effects than the standard cisplatin-based chemo-radiation. T…
Matched conditions: LARYNX
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Voice box transplant trial hopes to give speech back to patients
Disease control TerminatedThis study tests whether transplanting a donor voice box (larynx) can safely restore voice, swallowing, and breathing in people with severe larynx damage or who have had their larynx removed. Ten adults will receive the transplant and be followed for five years. The trial is curr…
Matched conditions: LARYNX
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 26, 2026 13:32 UTC